Category: Off-label Promotion

CHC-offLabel2

Kamp to Urge FDA to Provide Clear Guidance on Off-label Communication at November Hearing

CHC_offLabel

FDA to Hold Post-election Hearing on Off-label Communication

CHC_firstamendment3

Courts’ Support for “Truthful and Non-misleading” Speech Has Not Yet Resulted in FDA Policy Change

Drug Companies Should Be Able to Share Information with Payers

Commissioner of Food and Drugs Califf Lists Advertising, Labeling Among Priorities

Jury Says “Not Guilty” to Off-label Charges in Medical Device Case

Industry More Than Ready for FDA Off-label Communications Guidance

Rocky Political Road Ahead for Pharma Industry

Which Standard of Truth Will Be Used To Evaluate Non-misleading Ad Claims?